4.7 Article

Anti-tuberculosis neolignans from Piper regnellii

期刊

PHYTOMEDICINE
卷 20, 期 7, 页码 600-604

出版社

ELSEVIER GMBH
DOI: 10.1016/j.phymed.2013.01.005

关键词

Tuberculosis; Mycobacterium tuberculosis; Piper regnellii; Neolignans; REMA

资金

  1. CNPq
  2. CAPES, Brazil

向作者/读者索取更多资源

The present study determined the anti-Mycobacterium tuberculosis activities of supercritical CO2 extracts, neolignans eupomatenoid-5 (1), conocarpan (4) and eupomatenoid-3 (7) and their derivatives (2, 3, 5, 6, and 8) from Piper regnellii, as well as their cytotoxicities. The supercritical CO2 extract from leaves was purified by chromatographic methods, yielding compounds (1), (4) and (7), which were identified by H-1 NMR and comparison with literature data. Anti-M. tuberculosis activity (H(37)Rv and clinical isolates) was evaluated using a resazurin microtiter assay plate (REMA) to determine the MIC. The cytotoxicity assay was carried out in macrophages J774G.8 by sulforhodamine B colorimetric assay. The supercritical CO2 extracts from leaves and stems, and compound (4) showed activity against M. tuberculosis (MIC 15.6 mu g/ml). Compound (1) showed the best activity (MIC 1.9 mu g/ml), with good SI. Compounds (7) and (8) showed low activity against M. tuberculosis H(37)Rv. The derivative compounds did not show increased anti-M. tuberculosis activity. This is the first report, to our knowledge, to describe neolignans from P. regnellii with activity against M. tuberculosis, and compound (1) is a potential candidate for future antituberculosis drugs. (c) 2013 Elsevier GmbH. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据